Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Carcinoma, Ductal × Letrozole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 18 Polycystic Ovary Syndrome 5 Infertility 3 Neoplasm Metastasis 2 Leiomyoma 2 is to Identify Biomarkers That Could Predict the Efficacy of an Adjuvant Letrozol Treatment in Postmenopausal Breast Cancer Patients. 1 Patient Acceptance of Health Care 1 Ovarian Cysts 1 Locally Advanced Breast Cancer 1 Infertility, Female 1 Carcinoma, Ductal 1 Breast Carcinoma In Situ 1 Anovulation 1 Abortion, Spontaneous 1

Interventions

Specimen Handling 1 Letrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05183828 2026-01-26

Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer

University of Washington

Phase 4 Recruiting

Carcinoma, Ductal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡